HGF and cholestasis: Our data suggest that increased expression of Serpina1a would increase HGF and provide a therapeutic approach to limit the intestinal injury following cholestasis, analogous to a recent study, in which alpha-1 antitrypsin therapy was shown to decrease intestinal permeability and ameliorate acute colitis and chronic ileitis in a murine model (Collins et al. 2013).